Richard J. Thompson
- Hepatology top 1%
- Liver Diseases and Immunity 21
- Liver Disease and Transplantation 11
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 53
- Surgery top 1%
- Pediatric Hepatobiliary Diseases and Treatments 63
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 10
- Neurology top 2%
-
- Cardiac Valve Diseases and Treatments 10
-
- S100 Proteins and Annexins 10
- Co-authors
- Peter JacksonSandra StrautnieksJohn F DoranAmar P. DhillonJ. RodePamela A.M. KynochR. Mark GardinerIan N.M. Day
- Cited by
- HepatologyOncologySurgery
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Richard J. Thompson
240 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Hepatology 833
- Oncology 2.7k
- Surgery 2.8k
- Epidemiology 1.6k
- Neurology 646
Countries citing papers authored by Richard J. Thompson
This map shows the geographic impact of Richard J. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Thompson more than expected).
Fields of papers citing papers by Richard J. Thompson
This network shows the impact of papers produced by Richard J. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Thompson. The network helps show where Richard J. Thompson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard J. Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 1 | |
| 4 | The Natural Course of FIC1 Deficiency: Results from the Napped-Consortium | 2018 | 1 |
| 5 | Abstract 15892: Tricuspid Valve Leaflet Size in Hypoplastic Left Heart Syndrome Increases Between Stages 1 and 2, Maintaining Coaptation Index: A Longitudinal Three-Dimensional Echocardiography Study | 2013 | 1 |
| 6 | 2011 | 3 | |
| 7 | 2009 | 32 | |
| 8 | GLUTATHIONINE S-TRANSFERASE THETA 1 (GSTT1) MISMATCH DOES NOT ACCOUNT FOR POST LIVER TRANSPLANT DE NOVO AUTOIMMUNE HEPATITIS | 2009 | 5 |
| 9 | Cholestatic and metabolic liver diseases: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39: S611-15. | 2004 | 1 |
| 10 | Critical residues in the multidrug resistance 3 protein gene associated with adult onset cholangiopathy and intrahepatic cholestasis of pregnancy. | 2002 | 6 |
| 11 | Clinical and biochemical features of FIC1 (ATP8B1) and BSEP (ABCB11) disease. | 2002 | 6 |
| 12 | Allograft steatosis is a feature of progressive familial intrahepatic cholestasis, type 1 (FIC1 disease), treated by orthotopic liver transplantation (OLTX). | 2001 | 5 |
| 13 | Microvillus inclusion disease treated by small bowel transplantation: Development of progressive intrahepatic cholestasis with low serum concentrations of gamma-glutamyl transpeptidase activity. | 2001 | 4 |
| 14 | A novel syndrome: Progressive familial intrahepatic cholestasis associated with short stature, coloboma and cleft palate. | 2001 | 1 |
| 15 | De novo hepatocellular carcinoma (HCC) in allograft liver with background of hepatitis C virus infection, cirrhosis, and previous genetically distinct HCC in native liver. | 2001 | 1 |
| 16 | 1999 | 299 | |
| 17 | 1996 | 30 | |
| 18 | Pre operative visiting. | 1990 | 4 |
| 19 | "Keep Young and Beautiful": Surplus and Subversion in "Roman Scandals.". | 1990 | 3 |
| 20 | 1986 | 44 |
About Richard J. Thompson
Richard J. Thompson is a scholar working on Hepatology, Oncology and Surgery, having authored 248 papers that have together received 8.7k indexed citations. Recurring topics across this work include Pediatric Hepatobiliary Diseases and Treatments (63 papers), Drug Transport and Resistance Mechanisms (53 papers), Liver Diseases and Immunity (21 papers), Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (11 papers), Cardiac Valve Diseases and Treatments (10 papers), Hepatitis B Virus Studies (10 papers) and S100 Proteins and Annexins (10 papers). The work is most often cited by research in Hepatology (833 citations), Oncology (2.7k citations) and Surgery (2.8k citations). Richard J. Thompson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter Jackson, Sandra Strautnieks, John F Doran, Amar P. Dhillon, J. Rode, Pamela A.M. Kynoch, R. Mark Gardiner, Ian N.M. Day, Giorgina Mieli‐Vergani and Laura N. Bull. Their work appears in journals such as Cell, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.